x

Search for a clinical trial

* (*) mandatory field

103 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

FRANCE

NOUVELLE AQUITAINE
BORDEAUX

Recruiting trial
Ongoing trial
Tazemetostat Rollover Study (TRuST): An Open-Label, Rollover Study (Phase II) - FR
CLCC Institut Bergonié
Département d'oncologie médicale - Groupe Sarcomes

FRANCE

NOUVELLE AQUITAINE
BORDEAUX

GERMANY

Baden-Württemberg
HEIDELBERG

SAHA-I: A Phase II Study to investigate the efficacy and tolerability of Vorinostat in patients suffering from advanced, metastatic Soft Tissue Sarcoma - DE
Zentrum für Innere Medizin (Krehl-Klinik)
Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie

GERMANY

Baden-Württemberg
STUTTGART

GERMANY

Niedersachsen
HANNOVER

IRELAND

County Dublin
DUBLIN

Recruiting trial
Ongoing trial
European Paediatric Soft Tissue Sarcoma Study Group protocol for Localized Non-Rhabdomyosarcoma Soft Tissue Sarcomas 2005 (phase III) - IE
Our Lady's Children's Hospital
National Oncology/ Bone Marrow Transplant Centre and Haematology Department

SPAIN

Andalucía
SEVILLA

Recruiting trial
Ongoing trial
TRASTS: Phase I-II prospective trial, multicenter, open label, exploring the combination of Trabectedin plus Radiotherapy in Soft Tissue Sarcoma patients - ES
Hospital Universitario Virgen del Rocío
MUsculoSkeletal Tumor Board of Excellence Sevilla (MUSTBE SEVILLA)

SPAIN

Andalucía
SEVILLA

Recruiting trial
Ongoing trial
GEIS-51: Phase II multicenter trial of palbociclib in second line of advanced sarcomas with CDK4 overexpression - ES
Hospital Universitario Virgen del Rocío
MUsculoSkeletal Tumor Board of Excellence Sevilla (MUSTBE SEVILLA)

SPAIN

Andalucía
SEVILLA

Recruiting trial
Ongoing trial
GEIS-52: Phase I-II trial of sunitinib plus nivolumab after standard treatment in advanced soft tissue and bone sarcomas - ES
Hospital Universitario Virgen del Rocío
MUsculoSkeletal Tumor Board of Excellence Sevilla (MUSTBE SEVILLA)

SPAIN

Cataluña
BARCELONA

Localized Non-Rhabdomyosarcoma Soft Tissue Sarcomas (Phase III) (terminated)
Hospital Universitari Vall d'Hebron
Servicio de Oncología y Hematología Pediátricas

SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

UNITED KINGDOM

Greater Manchester
MANCHESTER

UNITED KINGDOM

South Yorkshire
SHEFFIELD

BELGIUM

VLAAMS BRABANT
LEUVEN

A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel with MORAb-004 in Metastatic Soft Tissue Sarcoma- BE (completed)
University Hospitals Leuven - Gasthuisberg
General medical oncology/Algemene Medische Oncologie

FRANCE

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCE

ILE-DE-FRANCE
VILLEJUIF

TSAR : A Randomized Phase III Trial Comparing Trabectedin (Yondelis®) to the Best Supportive Care in Patients With Advanced Soft Tissue Sarcoma
CLCC Institut Gustave Roussy
Département de Médecine oncologique - Sarcomes et tumeurs mésenchymateuses

FRANCE

NOUVELLE AQUITAINE
BORDEAUX

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

GERMANY

Nordrhein-Westfalen
MÜNSTER

Doxo: Phase II pharmacokinetic study to assess the age-dependency in the clearance of Doxorubicin in paediatric patients with Solid Tumours and Leukaemia - DE - Completed
Universitätsklinikum Münster
Klinik für Kinder- und Jugendmedizin - Pädiatrische Hämatologie und Onkologie

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

Phase II pharmacokinetic study to assess the age-dependency in the clearance of Doxorubicin in paediatric patients with Solid Tumours and Leukaemia - UK
Northern Institute for Cancer Research, Medical School, Newcastle University
Northern Institute for Cancer Research

Multinational clinical trial(s)